Amy Yip, Ph.D.
Amy Yip, Ph.D., is a business insights analyst on the oncology team at DRG, part of Clarivate. Prior to joining DRG, Dr. Yip worked as an analyst at GlobalData. She obtained her doctorate in molecular medicine at the Liggins Institute, part of the University of Auckland, where she investigated the impact of aberrant neurotrophic factor expression on hormone signaling pathways in breast cancer cells. Dr. Yip also holds a B.Sc., with first-class honors, in biomedical science from the University of Auckland.